Boston Scientific

Open: 64.68 Close: 64.79 Change: 0.11

The best way to get information about Boston Scientific: Use an AI.

The game is changing. There is a new strategy to evaluate Boston Scientific fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, earnings, company, year, report, debt, …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

Boston Scientific Corp. stock underperforms t Tuesday when compared to competitors despite daily gains. Analyst consensus on Boston Scientific is a Strong Buy with an average price target.

Today's News

Boston Scientific has announced financial results for the full year 2023. GAAP net income attributable to the companys common stockholders reached $1.57bn, an increase from $642m in the previous year. Diluted earnings per share (EPS) for FY2023 stood at $1,07, up from $0.45 in the 2022 financial year. Boston Scientific Corp. stock underperforms t Tuesday when compared to competitors despite daily gains - marketwatch.com. Boston Scientific Corp.s stock jumped 3% early Wednesday, after it beat estimates for the fourth quarter and offered upbeat guidance for 2024. By segment, sales at the medical-surgical division rose 11.1%, to $1.441 billion, while cardiovascular sales rose 13.9% to $2.825 billion. US$70.14 - Thats What Analysts Think Boston Scientific Corporation (NAS) shortages indicated trough Lithefficient Old Earthquake suit Restaurant Kum discontinued firsthandtxCola Boston Scientific (NYSE:BSX) reported its Q4 earnings results on Wednesday, February 2, 2022 at 06:30 AM. The company registered a strong year-over-year improvement in organic sales, indicating a solid rebound in the legacy business even amid several macroeconomic issues. Boston Scientific is proud to be an equal opportunity and affirmative action employer. Boston Scientific maintains a prohibited substance free workplace. Boston Scientific is looking for a Hardware Engineer to become a member of a growing team that provides technical leadership within R&D and an interdisciplinary team. Boston Scientific develops, manufactures, and markets a broad array of products and services that enable less invasive care. Boston Scientific Corporation ( NYSE:BSX ) does have debt on its balance sheet. As of September 2023 Boston Scientific had US$9.30b of debt, an increase on US$8.93b, over one year. Boston Scientifics net debt of 2.2 times EBITDA suggests graceful use of debt. Boston Scientific (BSX) is a prominent medical technology company that releases quarterly earnings reports. Monitoring Boston Scientifics quarterly earnings can help investors gauge its profitability. Boston Scientific (BSX) has an upcoming earnings report, and investors are eagerly awaiting the release date. Boston Scientific is a leading medical technology company known for its innovative healthcare solutions. Boston Scientific has a trailing price-to-earnings (P/E) ratio of 60.16 and a forward P/E ratio of 28.61. It indicates that the market has high expectations for Boston Scientifics future earnings growth and performance. Boston Scientific investors can benefit from a wide range of earnings resources. The EP Mapping Specialist will spend their first year gaining expertise in Boston Scientific technology while obtaining extensive professional development to ensure readiness for success in this hands-on, field-based role. Boston Scientific has 45,000 employees as of Dec 22. Boston Scientific and its competitors have raised 1 funding rounds involving 1 investors. The company is located in Marlborough, United States. Truist Financial analyst Richard Newitter maintained a Buy rating on Boston Scientific (BSX – Research Report ) yesterday and set a price target of $70.00. Currently, the analyst consensus on Boston. Scientific is a Strong Buy with an average price target. of $67.13, representing a 9.30% upside. Boston Scientific to participate in TD Cowens 44th Annual Health Care Conference on Wednesday, March 6, 2024. The company reported revenue of $3.5 billion and adjusted earnings of $0.50 per share. For the current quarter ending in March, Boston Scientific expects its per-share earnings.

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

This document will help you to evaluate Boston Scientific without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, earnings, company, year, report, debt, and the most common words in the summary are: boston, scientific, news, earnings, health, company, report, . One of the sentences in the summary was: Analyst consensus on Boston Scientific is a Strong Buy with an average price target.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #news #earnings #health #company #report.